Protein phosphatases in pancreatic islets

Journal of Endocrinology

Volumn 221, Issue 3, 2014, Pages

  Ortsäter, Henrik ^a,b   Grankvist, Nina ^c   Honkanen, Richard E ^d   Sjöholm, Åke ^a,b,d  

^a Biovation Park Telge   (Sweden)

^b Södertälje University   (Sweden)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Apoptosis; Diabetes; Insulin secretion; Islet cells; Phosphatase

Indexed keywords

CALCINEURIN; INSULIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE;

APOPTOSIS; CELL PROLIFERATION; HORMONE RELEASE; HUMAN; INSULIN RELEASE; MITOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

APOPTOSIS; DIABETES; INSULIN SECRETION; ISLET CELLS; PHOSPHATASE;

DIABETES MELLITUS; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 84901612351     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0002     Document Type: Review

References (227)

1. Ali A, Zhang J, Bao S, Liu I, Otterness D, Dean NM, Abraham RT & Wang XF 2004 Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes and Development 18 249-254. (doi:10.1101/gad. 1176004)
2. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J & Mustelin T 2004 Protein tyrosine phosphatases in the human genome. Cell 117 699-711. (doi:10.1016/j.cell.2004. 05.018)
3. Amable L, Grankvist N, Largen JW, Ortsater H, Sjoholm A & Honkanen RE 2011 Disruption of serine/threonine protein phosphatase 5 (PP5:PPP5c) in mice reveals a novel role for PP5 in the regulation of ultraviolet lightinduced phosphorylation of serine/threonine protein kinase Chk1 (CHEK1). Journal of Biological Chemistry 286 40413-40422. (doi:10.1074/jbc.M111.244053)
4. American Diabetes Association 2013 Economic costs of diabetes in the U.. in 2012. Diabetes Care 36 1033-1046. (doi:10.2337/dc12-2625)
5. Ämmälä C, Eliasson L, Bokvist K, Berggren PO, Honkanen RE, Sjöholm A & Rorsman P 1994 Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic b cells. PNAS 91 4343-4347. (doi:10.1073/pnas.91. 10.4343)
6. Ammon HP, Heurich RO, Kolb HA, Lang F, Schaich R, Drews G & Leiers T 1996 The phosphatase inhibitor okadaic acid blocks KCl-depolarization-induced rise of cytosolic calcium of rat insulinoma cells (RINm5F). Naunyn-Schmiedeberg's Archives of Pharmacology 354 95-101. (doi:10.1007/BF00178708)
7. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK & Moller NP 2001 Structural and evolutionary relationships among protein tyrosine phosphatase domains. Molecular and Cellular Biology 21 7117-7136. (doi:10.1128/MCB.21.21.7117-7136.2001)
8. Andreeva AV & Kutuzov MA 1999 RdgC/PP5-related phosphatases: novel components in signal transduction. Cellular Signalling 11 555-562. (doi:10.1016/S0898-6568(99)00032-7)
9. Arkhammar P, Juntti-Berggren L, Larsson O, Welsh M, Nanberg E, Sjoholm A, Kohler M & Berggren PO 1994 Protein kinase C modulates the insulin secretory process by maintaining a proper function of the b-cell voltage-activated Ca2C channels. Journal of Biological Chemistry 269 2743-2749.
10. Arora DK, Machhadieh B, Matti A, Wadzinski BE, Ramanadham S & Kowluru A 2013 High glucose exposure promotes activation of protein phosphatase 2A in rodent islets and INS-1 832/13 b-cells by increasing the posttranslational carboxylmethylation of its catalytic subunit. Endocrinology 155 380-391. (doi:10.1210/en.2013-1773)
11. Ashcroft FM & Rorsman P 2012 Diabetes mellitus and the b cell: the last ten years. Cell 148 1160-1171. (doi:10.1016/j.cell.2012.02.010)
12. Ashcroft FM, Harrison DE & Ashcroft SJ 1984 Glucose induces closure of single potassium channels in isolated rat pancreatic b-cells. Nature 312 446-448. (doi:10.1038/312446a0)
13. Avram D, Ranta F, Hennige AM, Berchtold S, Hopp S, Haring HU, Lang F & Ullrich S 2008 IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation. Cellular Physiology and Biochemistry 21 455-462. (doi:10.1159/000129638)
14. Barford D, Flint AJ & Tonks NK 1994 Crystal structure of human protein tyrosine phosphatase 1B. Science 263 1397-1404. (doi:10.1126/science. 8128219)
15. Barlow AD, Xie J, Moore CE, Campbell SC, Shaw JA, Nicholson ML & Herbert TP 2012 Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2). Diabetologia 55 1355-1365. (doi:10.1007/s00125-012-2475-7)
16. Becker W, Kentrup H, Klumpp S, Schultz JE & Joost HG 1994 Molecular cloning of a protein serine/threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. Journal of Biological Chemistry 269 22586-22592.
17. Bell GI & Polonsky KS 2001 Diabetes mellitus and genetically programmed defects in b-cell function. Nature 414 788-791. (doi:10.1038/414788a)
18. Bernal-Mizrachi E, Cras-Meneur C, Ye BR, Johnson JD & Permutt MA 2010 Transgenic overexpression of active calcineurin in b-cells results in decreased b-cell mass and hyperglycemia. PLoS ONE 5 e11969. (doi:10.1371/journal.pone.0011969)
19. Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, Chen CH, Song C, Garza D & Labow M 2004 Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Current Biology 14 2156-2161. (doi:10.1016/j.cub.2004.11.002)
20. Blanchetot C, Chagnon M, Dube N, Halle M & Tremblay ML 2005 Substrate-trapping techniques in the identification of cellular PTP targets. Methods 35 44-53. (doi:10.1016/j.ymeth.2004.07.007)
21. Bollen M, Peti W, Ragusa MJ & Beullens M 2010 The extended PP1 toolkit:designed to create specificity. Trends in Biochemical Sciences 35 450-458. (doi:10.1016/j.tibs.2010.03.002)
22. Breitkreutz A, Choi H, Sharom JR, Boucher L, Neduva V, Larsen B, Lin ZY, Breitkreutz BJ, Stark C, Liu G et al. 2010 A global protein kinase and phosphatase interaction network in yeast. Science 328 1043-1046. (doi:10.1126/science.1176495)
23. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA & Butler PC 2003 b-cell deficit and increased b-cell apoptosis in humans with type 2 diabetes. Diabetes 52 102-110. (doi:10.2337/diabetes.52.1.102)
24. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T & Eizirik DL 2001 Identification of novel cytokine-induced genes in pancreatic b-cells by high-density oligonucleotide arrays. Diabetes 50 909-920. (doi:10.2337/diabetes.50.5.909)
25. Chen J & Ostenson CG 2005 Inhibition of protein-tyrosine phosphatases stimulates insulin secretion in pancreatic islets of diabetic Goto-Kakizaki rats. Pancreas 30 314-317. (doi:10.1097/01.mpa. 0000161887.25115.6c)
26. Chen MS, Silverstein AM, Pratt WB & Chinkers M 1996 The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. Journal of Biological Chemistry 271 32315-32320. (doi:10.1074/jbc.271.50.32315)
27. Chen J, Peterson RT & Schreiber SL 1998 a4 associates with protein phosphatases 2A, 4, and 6. Biochemical and Biophysical Research Communications 247 827-832. (doi:10.1006/bbrc.1998.8792)
28. Chen GI, Tisayakorn S, Jorgensen C, D'Ambrosio LM, Goudreault M & Gingras AC 2008 PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. Journal of Biological Chemistry 283 29273-29284. (doi:10.1074/jbc.M803443200)
29. Cher C, Tremblay MH, Barber JR, Chung Ng S & Zhang B 2010 Identification of chaulmoogric acid as a small molecule activator of protein phosphatase 5. Applied Biochemistry and Biotechnology 160 1450-1459. (doi:10.1007/s12010-009-8647-3)
30. Chinkers M 2001 Protein phosphatase 5 in signal transduction. Trends in Endocrinology and Metabolism 12 28-32. (doi:10.1016/S1043-2760 (00)00335-0)
31. Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, Dogusan Z, Flamez D, Boyce M, Yuan J & Eizirik DL 2007 Selective inhibition of eukaryotic translation initiation factor 2a dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic b-cell dysfunction and apoptosis. Journal of Biological Chemistry 282 3989-3997. (doi:10.1074/jbc.M607627200)
32. Cohen PT 2002 Protein phosphatase 1 - targeted in many directions. Journal of Cell Science 115 241-256.
33. Colca JR, Kotagal N, Lacy PE, Brooks CL, Norling L, Landt M & McDaniel ML 1984 Glucose-stimulated protein phosphorylation in the pancreatic islet. Biochemical Journal 220 529-537.
34. Cook DL & Hales CN 1984 Intracellular ATP directly blocks KC channels in pancreatic B-cells. Nature 311 271-273. (doi:10.1038/311271a0)
35. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M & Ferguson RM 2002 Patient survival after renal transplantation: IV. Impact of posttransplant diabetes. Kidney International 62 1440-1446. (doi:10.1111/j.1523-1755.2002.kid582.x)
36. Couzens AL, Knight JD, Kean MJ, Teo G, Weiss A, Dunham WH, Lin ZY, Bagshaw RD, Sicheri F, Pawson T et al. 2013 Protein interaction network of the Mammalian hippo pathway reveals mechanisms of kinase-phosphatase interactions. Science Signaling 6 rs15. (doi:10.1126/scisignal.2004712)
37. Crabtree GR & Olson EN 2002 NFAT signaling: choreographing the social lives of cells. Cell 109(Suppl) S67-S79. (doi:10.1016/S0092-8674(02) 00699-2)
38. Das AK, Cohen PW& Barford D 1998 The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO Journal 17 1192-1199. (doi:10.1093/emboj/17.5.1192)
39. Detimary P, Jonas JC & Henquin JC 1995 Possible links between glucose-induced changes in the energy state of pancreatic B cells and insulin release. Unmasking by decreasing a stable pool of adenine nucleotides in mouse islets. Journal of Clinical Investigation 96 1738-1745. (doi:10.1172/JCI118219)
40. Ebihara K, Fukunaga K, Matsumoto K, Shichiri M & Miyamoto E 1996 Cyclosporin A stimulation of glucose-induced insulin secretion in MIN6 cells. Endocrinology 137 5255-5263.
41. Endicott JA, Noble ME & Johnson LN 2012 The structural basis for control of eukaryotic protein kinases. Annual Review of Biochemistry 81 587-613. (doi:10.1146/annurev-biochem-052410-090317)
42. Fagin JA, Ikejiri K & Levin SR 1987 Insulinotropic effects of vanadate. Diabetes 36 1448-1452. (doi:10.2337/diab.36.12.1448)
43. Fernandez-Ruiz R, Vieira E, Garcia-Roves PM & Gomis R 2014 Protein tyrosine phosphatase-1B modulates pancreatic b-cell mass. PLoS One 9 e90344. (doi:10.1371/journal.pone.0090344)
44. Fischer EH, Graves DJ, Crittenden ER & Krebs EG 1959 Structure of the site phosphorylated in the phosphorylase b to a reaction. Journal of Biological Chemistry 234 1698-1704.
45. Flint AJ, Tiganis T, Barford D & Tonks NK 1997 Development of "substratetrapping" mutants to identify physiological substrates of protein tyrosine phosphatases. PNAS 94 1680-1685. (doi:10.1073/pnas.94.5. 1680)
46. Fransson L, Rosengren V, Saha TK, Grankvist N, Islam T, Honkanen RE, Sjöholm Å & Ortsäter H 2013 Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and b-cells. Molecular and Cellular Endocrinology 383 126-136. (doi:10.1016/j.mce.2013.12.010)
47. Gagliardino JJ, Krinks MH & Gagliardino EE 1991 Identification of the calmodulin-regulated protein phosphatase, calcineurin, in rat pancreatic islets. Biochimica et Biophysica Acta 1091 370-373. (doi:10.1016/0167-4889(91)90202-9)
48. Gagliardino JJ, Rossi PF & Garcia ME 1997 Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets. Acta Diabetologia 34 6-9. (doi:10.1007/s005920050057)
49. Gembal M, Gilon P & Henquin JC 1992 Evidence that glucose can control insulin release independently from its action on ATP-sensitive KC channels in mouse B cells. Journal of Clinical Investigation 89 1288-1295. (doi:10.1172/JCI115714)
50. Gentile S, Darden T, Erxleben C, Romeo C, Russo A, Martin N, Rossie S & Armstrong DL 2006 Rac GTPase signaling through the PP5 protein phosphatase. PNAS 103 5202-5206. (doi:10.1073/pnas.0600080103)
51. Golden TA & Honkanen RE 2003 Regulating the expression of protein phosphatase type 5. Methods in Enzymology 366 372-390.
52. Golden T, Swingle M & Honkanen RE 2008 The role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancer. Cancer Metastasis Reviews 27 169-178. (doi:10.1007/s10555-008-9125-z)
53. Goodyer WR, Gu X, Liu Y, Bottino R, Crabtree GR & Kim SK 2012 Neonatal b cell development in mice and humans is regulated by calcineurin/NFAT. Developmental Cell 23 21-34. (doi:10.1016/j.devcel.2012.05.014)
54. Grankvist N, Amable L, Honkanen RE, Sjöholm Å & Ortsäter H 2012 Serine/threonine protein phosphatase 5 regulates glucose homeostasis in vivo and apoptosis signalling in mouse pancreatic islets and clonal MIN6 cells. Diabetologia 55 2005-2015. (doi:10.1007/s00125-012-2541-1)
55. Grankvist N, Honkanen RE, Sjöholm Å & Ortsäter H 2013 Genetic disruption of protein phosphatase 5 in mice prevents high-fat diet feeding-induced weight gain. FEBS Letters 587 3869-3874. (doi:10.1016/j.febslet.2013.10.022)
56. Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE et al. 2003 Allosteric activators of glucokinase: potential role in diabetes therapy. Science 301 370-373. (doi:10.1126/science.1084073)
57. Group US 1998a Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 854-865. (doi:10.1016/S0140-6736(05)61359-1)
58. Group US 1998b Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 837-853. (doi:10.1016/S0140-6736(05)61359-1)
59. Grunnet LG, Aikin R, Tonnesen MF, Paraskevas S, Blaabjerg L, Storling J, Rosenberg L, Billestrup N, Maysinger D & Mandrup-Poulsen T 2009 Proinflammatory cytokines activate the intrinsic apoptotic pathway in b-cells. Diabetes 58 1807-1815. (doi:10.2337/db08-0178)
60. Haby C, Larsson O, Islam MS, Aunis D, Berggren PO & Zwiller J 1994 Inhibition of serine/threonine protein phosphatases promotes opening of voltage-activated L-type Ca2C channels in insulin-secreting cells. Biochemical Journal 298 341-346.
61. Hedeskov CJ 1980 Mechanism of glucose-induced insulin secretion. Physiological Reviews 60 442-509.
62. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR & Kim SK 2006 Calcineurin/NFAT signalling regulates pancreatic b-cell growth and function. Nature 443 345-349. (doi:10.1038/nature05097)
63. Henquin JC, Nenquin M, Szollosi A, Kubosaki A & Notkins AL 2008 Insulin secretion in islets from mice with a double knockout for the dense core vesicle proteins islet antigen-2 (IA-2) and IA-2b. Journal of Endocrinology 196 573-581. (doi:10.1677/JOE-07-0496)
64. Heroes E, Lesage B, Gornemann J, Beullens M, Van Meervelt L & Bollen M 2013 The PP1 binding code: a molecular-lego strategy that governs specificity. FEBS Journal 280 584-595. (doi:10.1111/j.1742-4658.2012. 08547.x)
65. Hinds TD Jr, Stechschulte LA, Cash HA, Whisler D, Banerjee A, Yong W, Khuder SS, Kaw MK, Shou W, Najjar SM et al. 2011 Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-g (PPARg). Journal of Biological Chemistry 286 42911-42922. (doi:10.1074/jbc.M111.311662)
66. Hiraga A, Kikuchi K, Tamura S & Tsuiki S 1981 Purification and characterization of Mg2C-dependent glycogen synthase phosphatase (phosphoprotein phosphatase IA) from rat liver. European Journal of Biochemistry 119 503-510. (doi:10.1111/j.1432-1033.1981.tb05636.x)
67. Hisatomi M, Hidaka H & Niki I 1996 Ca2C/calmodulin and cyclic 3,50 adenosine monophosphate control movement of secretory granules through protein phosphorylation/dephosphorylation in the pancreatic b-cell. Endocrinology 137 4644-4649.
68. Honkanen RE & Golden T 2002 Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? CurrentMedicinal Chemistry 9 2055-2075. (doi:10.2174/0929867023368836)
69. Huang X & Honkanen RE 1998 Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC). Journal of Biological Chemistry 273 1462-1468. (doi:10.1074/jbc.273.3.1462)
70. Huang X, Swingle MR & Honkanen RE 2000 Photoreceptor serine/threonine protein phosphatase type 7: cloning, expression, and functional analysis. Methods in Enzymology 315 579-593.
71. Huang S, Shu L, Easton J, Harwood FC, Germain GS, Ichijo H & Houghton PJ 2004 Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. Journal of Biological Chemistry 279 36490-36496. (doi:10.1074/jbc.M401208200)
72. Hunter T & Sefton BM 1980 Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. PNAS 77 1311-1315. (doi:10.1073/pnas. 77.3.1311)
73. Hunter T, Sefton BM & Beemon K 1980 Studies on the structure and function of the avian sarcoma virus transforming-gene product. Cold Spring Harbor Symposia on Quantitative Biology 44 931-941. (doi:10.1101/SQB.1980.044.01.100)
74. Hussain MA, Porras DL, Rowe MH, West JR, Song WJ, Schreiber WE & Wondisford FE 2006 Increased pancreatic b-cell proliferation mediated by CREB binding protein gene activation. Molecular and Cellular Biology 26 7747-7759. (doi:10.1128/MCB.02353-05)
75. Inada A, Hamamoto Y, Tsuura Y, Miyazaki J, Toyokuni S, Ihara Y, Nagai K, Yamada Y, Bonner-Weir S & Seino Y 2004 Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic b cells. Molecular and Cellular Biology 24 2831-2841. (doi:10.1128/MCB.24.7.2831-2841.2004)
76. Jangati GR, Veluthakal R & Kowluru A 2006 siRNA-mediated depletion of endogenous protein phosphatase 2Aca markedly attenuates ceramideactivated protein phosphatase activity in insulin-secreting INS-832/13 cells. Biochemical and Biophysical Research Communications 348 649-652. (doi:10.1016/j.bbrc.2006.07.100)
77. Jangati GR, Veluthakal R, Susick L, Gruber SA & Kowluru A 2007 Depletion of the catalytic subunit of protein phosphatase-2A (PP2Ac) markedly attenuates glucose-stimulated insulin secretion in pancreatic b-cells. Endocrine 31 248-253. (doi:10.1007/s12020-007-0046-3)
78. Janssens V & Goris J 2001 Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 353 417-439. (doi:10.1042/0264-6021:3530417)
79. Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M & Screaton RA 2008 Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. PNAS 105 10161-10166. (doi:10.1073/pnas. 0800796105)
80. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M & Montminy M 2003 cAMP promotes pancreatic b-cell survival via CREB-mediated induction of IRS2. Genes and Development 17 1575-1580. (doi:10.1101/gad.1097103)
81. Johnson SA & Hunter T 2005 Kinomics: methods for deciphering the kinome. Nature Methods 2 17-25. (doi:10.1038/nmeth731)
82. Jonas JC, Gilon P & Henquin JC 1998 Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2C in mouse pancreatic b-cells. Diabetes 47 1266-1273.
83. Jones PM & Persaud SJ 1998 Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic b-cells. Endocrine Reviews 19 429-461.
84. Kahn SE & Halban PA 1997 Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46 1725-1732. (doi:10.2337/diab.46.11.1725)
85. Kasiske BL, Snyder JJ, Gilbertson D & Matas AJ 2003 Diabetes mellitus after kidney transplantation in the United States. American Journal of Transplantation 3 178-185. (doi:10.1034/j.1600-6143.2003.00010.x)
86. Klee CB, Draetta GF & Hubbard MJ 1988 Calcineurin. Advances in Enzymology and Related Areas of Molecular Biology 61 149-200.
87. Kloeker S, Reed R, McConnell JL, Chang D, Tran K, Westphal RS, Law BK, Colbran RJ, Kamoun M, Campbell KS et al. 2003 Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with a4 protein. Protein Expression and Purification 31 19-33. (doi:10.1016/S1046-5928(03)00141-4)
88. Klumpp S, Thissen MC & Krieglstein J 2006 Protein phosphatases types 2Ca and 2Cb in apoptosis. Biochemical Society Transactions 34 1370-1375. (doi:10.1042/BST0341370)
89. Komatsu M, Schermerhorn T, Noda M, Straub SG, Aizawa T & Sharp GW 1997 Augmentation of insulin release by glucose in the absence of extracellular Ca2C: new insights into stimulus-secretion coupling. Diabetes 46 1928-1938. (doi:10.2337/diab.46.12.1928)
90. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P et al. 2005 The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 1109-1111. (doi:10.1038/nature03967)
91. Koro CE, Bowlin SJ, Bourgeois N & Fedder DO 2004 Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes:a preliminary report. Diabetes Care 27 17-20. (doi:10.2337/diacare.27.1.17)
92. Kowluru A 2005 Novel regulatory roles for protein phosphatase-2A in the islet b cell. Biochemical Pharmacology 69 1681-1691. (doi:10.1016/j.bcp. 2005.03.018)
93. Kowluru A & Matti A 2012 Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences. Biochemical Pharmacology 84 591-597. (doi:10.1016/j.bcp.2012.05.003)
94. Kowluru A & Metz SA 1997 Ceramide-activated protein phosphatase-2A activity in insulin-secreting cells. FEBS Letters 418 179-182. (doi:10.1016/S0014-5793(97)01379-3)
95. Kowluru A, Seavey SE, Rabaglia ME, Nesher R & Metz SA 1996 Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion. Endocrinology 137 2315-2323.
96. Kowluru A, Chen HQ, Modrick LM & Stefanelli C 2001 Activation of acetyl-CoA carboxylase by a glutamate- and magnesium-sensitive protein phosphatase in the islet b-cell. Diabetes 50 1580-1587. (doi:10.2337/diabetes.50.7.1580)
97. Krautheim A, Rustenbeck I & Steinfelder HJ 1999 Phosphatase inhibitors induce defective hormone secretion in insulin-secreting cells and entry into apoptosis. Experimental and Clinical Endocrinology & Diabetes 107 29-34. (doi:10.1055/s-0029-1212069)
98. Krebs EG, Graves DJ & Fischer EH 1959 Factors affecting the activity of muscle phosphorylase b kinase. Journal of Biological Chemistry 234 2867-2873.
99. Krieglstein J, Hufnagel B, Dworak M, Schwarz S, Kewitz T, Reinbold M & Klumpp S 2008 Influence of various fatty acids on the activity of protein phosphatase type 2C and apoptosis of endothelial cells and macrophages. European Journal of Pharmaceutical Sciences 35 397-403. (doi:10.1016/j.ejps.2008.08.007)
100. von Kriegsheim A, Pitt A, Grindlay GJ, Kolch W & Dhillon AS 2006 Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nature Cell Biology 8 1011-1016. (doi:10.1038/ncb1465)
101. Kuehnen P, Laubner K, Raile K, Schofl C, Jakob F, Pilz I, Path G & Seufert J 2011 Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic b-cells and human pancreatic islets. Endocrinology 152 1800-1808. (doi:10.1210/en.2010-1094)
102. Kutuzov MA, Andreeva AV & Voyno-Yasenetskaya TA 2005 Regulation of apoptosis signal-regulating kinase 1 (ASK1) by polyamine levels via protein phosphatase 5. Journal of Biological Chemistry 280 25388-25395. (doi:10.1074/jbc.M413202200)
103. Ladriere L, Igoillo-Esteve M, Cunha DA, Brion JP, Bugliani M, Marchetti P, Eizirik DL & Cnop M 2010 Enhanced signaling downstream of ribonucleic acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets. Journal of Clinical Endocrinology and Metabolism 95 1442-1449. (doi:10.1210/jc.2009-2322)
104. Lambrecht C, Haesen D, Sents W, Ivanova E & Janssens V 2013 Structure, regulation, and pharmacological modulation of PP2A phosphatases. Methods in Molecular Biology 1053 283-305.
105. Lammers T & Lavi S 2007 Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling. Critical Reviews in Biochemistry and Molecular Biology 42 437-461. (doi:10.1080/10409230701693342)
106. Langberg EC, Gu HF, Nordman S, Efendic S & Ostenson CG 2007 Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians. European Journal of Endocrinology 157 459-464. (doi:10.1530/EJE-07-0114)
107. Larsson O, Barker CJ, Sjoholm A, Carlqvist H, Michell RH, Bertorello A, Nilsson T, Honkanen RE, Mayr GW, Zwiller J et al. 1997 Inhibition of phosphatases and increased Ca2C channel activity by inositol hexakisphosphate. Science 278 471-474. (doi:10.1126/science.278.5337.471)
108. Lawrence MC, Bhatt HS, Watterson JM & Easom RA 2001 Regulation of insulin gene transcription by a Ca(2C)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Molecular Endocrinolgy 15 1758-1767. (doi:10.1210/mend.15.10.0702)
109. Lawrence MC, Bhatt HS & Easom RA 2002 NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51 691-698. (doi:10.2337/diabetes.51.3.691)
110. Lee YC & Nielsen JH 2009 Regulation of b cell replication. Molecular and Cellular Endocrinology 297 18-27. (doi:10.1016/j.mce.2008.08.033)
111. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Lee JH, Han SY, Lee HK, Park JY, Oh RR et al. 1999 Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues. APMIS 107 1101-1108. (doi:10.1111/j.1699-0463.1999.tb01515.x)
112. Lehtihet M, Honkanen RE & Sjoholm A 2004 Inositol hexakisphosphate and sulfonylureas regulate b-cell protein phosphatases. Biochemical and Biophysical Research Communications 316 893-897. (doi:10.1016/j.bbrc. 2004.02.144)
113. Lehtihet M, Webb DL, Honkanen RE & Sjoholm A 2005 Glutamate inhibits protein phosphatases and promotes insulin exocytosis in pancreatic b-cells. Biochemical and Biophysical Research Communications 328 601-607. (doi:10.1016/j.bbrc.2005.01.024)
114. Lernmark A, Nielsen DA, Parman AU, Sehlin J, Steiner DF & Taljedal IB 1980 Cation-activated phosphatase activities in islet cell plasma membrane preparations. Hormone and Metabolic Research. Supplement Series (Suppl 10) 55-61.
115. Lipson LG, Siegel E, Wollheim CB & Sharp GW 1979 Insulin release during fasting: studies on adenylate cyclase, phosphodiesterase, protein kinase, and phosphoprotein phosphatase in isolated islets of langerhans of the rat. Endocrinology 105 702-707. (doi:10.1210/endo-105-3-702)
116. Lobner K, Steinbrenner H, Roberts GA, Ling Z, Huang GC, Piquer S, Pipeleers DG, Seissler J & Christie MR 2002 Different regulated expression of the tyrosine phosphatase-like proteins IA-2 and phogrin by glucose and insulin in pancreatic islets: relationship to development of insulin secretory responses in early life. Diabetes 51 2982-2988. (doi:10.2337/diabetes.51.10.2982)
117. Lubert EJ, Hong Y & Sarge KD 2001 Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A: evidence for a heterotrimeric form of protein phosphatase 5. Journal of Biological Chemistry 276 38582-38587. (doi:10.1074/jbc.M106906200)
118. MacDonald MJ & Fahien LA 2000 Glutamate is not a messenger in insulin secretion. Journal of Biological Chemistry 275 34025-34027. (doi:10.1074/jbc.C000411200)
119. Maechler P & Wollheim CB 1999 Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402 685-689. (doi:10.1038/45280)
120. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA & Donath MY 2002 Glucose-induced b cell production of IL-1b contributes to glucotoxicity in human pancreatic islets. Journal of Clinical Investigation 110 851-860. (doi:10.1172/JCI200215318)
121. Manning G, Whyte DB, Martinez R, Hunter T & Sudarsanam S 2002 The protein kinase complement of the human genome. Science 298 1912-1934. (doi:10.1126/science.1075762)
122. Matschinsky FM, Glaser B & Magnuson MA 1998 Pancreatic b-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 47 307-315. (doi:10.2337/diabetes.47. 3.307)
123. Mayer P, Jochum C, Schatz H & Pfeiffer A 1994 Okadaic acid indicates a major function for protein phosphatases in stimulus-response coupling of RINm5F rat insulinoma cells. Experimental and Clinical Endocrinology 102 313-319. (doi:10.1055/s-0029-1211297)
124. Meetoo D, McGovern P & Safadi R 2007 An epidemiological overview of diabetes across the world. British Journal of Nutrition 16 1002-1007.
125. Meglasson MD & Matschinsky FM 1986 Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes/Metabolism Reviews 2 163-214. (doi:10.1002/dmr.5610020301)
126. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza RA & Butler PC 2008 b-cell replication is the primary mechanism subserving the postnatal expansion of b-cell mass in humans. Diabetes 57 1584-1594. (doi:10.2337/db07-1369)
127. Merritt SE, Mata M, Nihalani D, Zhu C, Hu X & Holzman LB 1999 The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate. Journal of Biological Chemistry 274 10195-10202. (doi:10.1074/jbc.274. 15.10195)
128. Mkaddem SB, Werts C, Goujon JM, Bens M, Pedruzzi E, Ogier-Denis E & Vandewalle A 2009 Heat shock protein gp96 interacts with protein phosphatase 5 and controls toll-like receptor 2 (TLR2)-mediated activation of extracellular signal-regulated kinase (ERK) 1/2 in posthypoxic kidney cells. Journal of Biological Chemistry 284 12541-12549. (doi:10.1074/jbc.M808376200)
129. Moore F, Colli ML, Cnop M, Esteve MI, Cardozo AK, Cunha DA, Bugliani M, Marchetti P & Eizirik DL 2009 PTPN2, a candidate gene for type 1 diabetes, modulates interferon-g-induced pancreatic b-cell apoptosis. Diabetes 58 1283-1291. (doi:10.2337/db08-1510)
130. Moorhead GB, Trinkle-Mulcahy L & Ulke-Lemee A 2007 Emerging roles of nuclear protein phosphatases. Nature Reviews. Molecular Cell Biology 8 234-244. (doi:10.1038/nrm2126)
131. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H & Ichijo H 2001 Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO Journal 20 6028-6036. (doi:10.1093/emboj/20.21.6028)
132. Mullen TD, Hannun YA & Obeid LM 2012 Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochemical Journal 441 789-802. (doi:10.1042/BJ20111626)
133. Murphy LI & Jones PM 1996 Phospho-serine/threonine phosphatases in rat islets of Langerhans: identification and effect on insulin secretion. Molecular and Cellular Endocrinology 117 195-202. (doi:10.1016/0303-7207(95)03747-0)
134. Nakamura S, Tanigawa K, Kawaguchi M, Inoue Y, Xu G, Nagami H, Teramoto M, Kato Y & Tamura K 1995 Effect of chronic vanadate administration in partially depancreatized rats. Diabetes Research and Clinical Practice 27 51-59. (doi:10.1016/0168-8227(94)01012-O)
135. Newgard CB & McGarry JD 1995 Metabolic coupling factors in pancreatic b-cell signal transduction. Annual Review of Biochemistry 64 689-719. (doi:10.1146/annurev.bi.64.070195.003353)
136. Nolen B, Taylor S & Ghosh G 2004 Regulation of protein kinases; controlling activity through activation segment conformation. Molecular Cell 15 661-675. (doi:10.1016/j.molcel.2004.08.024)
137. Novoa I, Zhang Y, Zeng H, Jungreis R, Harding HP & Ron D 2003 Stress-induced gene expression requires programmed recovery from translational repression. EMBO Journal 22 1180-1187. (doi:10.1093/emboj/cdg112)
138. Ollendorff V & Donoghue DJ 1997 The serine/threonine phosphatase PP5 interacts with CDC16 and CDC27, two tetratricopeptide repeat-containing subunits of the anaphase-promoting complex. Journal of Biological Chemistry 272 32011-32018. (doi:10.1074/jbc.272. 51.32011)
139. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P & Mann M 2006 Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127 635-648. (doi:10.1016/j.cell.2006.09.026)
140. Oprescu AI, Bikopoulos G, Naassan A, Allister EM, Tang C, Park E, Uchino H, Lewis GF, Fantus IG, Rozakis-Adcock M et al. 2007 Free fatty acidinduced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes 56 2927-2937. (doi:10.2337/db07-0075)
141. Ortsäter H & Sjöholm A 2007 A busy cell - endoplasmic reticulum stress in the pancreatic b-cell. Molecular and Cellular Endocrinology 277 1-5. (doi:10.1016/j.mce.2007.06.006)
142. Östenson CG, Sandberg-Nordqvist AC, Chen J, Hallbrink M, Rotin D, Langel U & Efendic S 2002 Overexpression of protein-tyrosine phosphatase PTP sigma is linked to impaired glucose-induced insulin secretion in hereditary diabetic Goto-Kakizaki rats. Biochemical and Biophysical Research Communications 291 945-950. (doi:10.1006/bbrc. 2002.6536)
143. Ozbay LA, Smidt K, Mortensen DM, Carstens J, Jorgensen KA & Rungby J 2011 Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E b-cells. British Journal of Pharmacology 162 136-146. (doi:10.1111/j.1476-5381.2010.01018.x)
144. Palanivel R, Veluthakal R & Kowluru A 2004 Regulation by glucose and calcium of the carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting INS-1 cells. American Journal of Physiology. Endocrinology and Metabolism 286 E1032-E1041. (doi:10.1152/ajpendo.00587.2003)
145. Palanivel R, Veluthakal R, McDonald P & Kowluru A 2005 Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamateand magnesium-activated protein phosphatase in the pancreatic b cell:defective regulation in the diabetic GK rat islet. Endocrine 26 71-77. (doi:10.1385/ENDO:26:1:071)
146. Pato MD & Adelstein RS 1983 Characterization of a Mg2C-dependent phosphatase from Turkey gizzard smooth muscle. Journal of Biological Chemistry 258 7055-7058.
147. Pederson RA, Ramanadham S, Buchan AM & McNeill JH 1989 Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. Diabetes 38 1390-1395. (doi:10.2337/diab.38.11.1390)
148. Peiris H, Raghupathi R, Jessup CF, Zanin MP, Mohanasundaram D, Mackenzie KD, Chataway T, Clarke JN, Brealey J, Coates PT et al. 2012 Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, b-cell dysfunction, and diabetes. Endocrinology 153 5212-5221. (doi:10.1210/en.2011-2149)
149. Plaumann S, Blume R, Borchers S, Steinfelder HJ, Knepel W & Oetjen E 2008 Activation of the dual-leucine-zipper-bearing kinase and induction of b-cell apoptosis by the immunosuppressive drug cyclosporin A. Molecular Pharmacology 73 652-659. (doi:10.1124/mol.107.040782)
150. Ramsey AJ & Chinkers M 2002 Identification of potential physiological activators of protein phosphatase 5. Biochemistry 41 5625-5632. (doi:10.1021/bi016090h)
151. Ramsey AJ, Russell LC, Whitt SR & Chinkers M 2000 Overlapping sites of tetratricopeptide repeat protein binding and chaperone activity in heat shock protein 90. Journal of Biological Chemistry 275 17857-17862. (doi:10.1074/jbc.M001625200)
152. Ranta F, Avram D, Berchtold S, Dufer M, Drews G, Lang F & Ullrich S 2006 Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes 55 1380-1390. (doi:10.2337/db05-1220)
153. Ranta F, Dufer M, Stork B, Wesselborg S, Drews G, Haring HU, Lang F & Ullrich S 2008 Regulation of calcineurin activity in insulin-secreting cells: stimulation by Hsp90 during glucocorticoid-induced apoptosis. Cellular Signalling 20 1780-1786. (doi:10.1016/j.cellsig.2008.06.003)
154. Ratcliff H & Jones PM 1993 Effects of okadaic acid on insulin secretion from rat islets of Langerhans. Biochimica et Biophysica Acta 1175 188-191. (doi:10.1016/0167-4889(93)90022-H)
155. Ravnskjaer K, Boergesen M, Dalgaard LT & Mandrup S 2006 Glucoseinduced repression of PPARa gene expression in pancreatic b-cells involves PP2A activation and AMPK inactivation. Journal of Molecular Endocrinology 36 289-299. (doi:10.1677/jme.1.01965)
156. Redmon JB, Olson LK, Armstrong MB, Greene MJ & Robertson RP 1996 Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. Journal of Clinical Investigation 98 2786-2793. (doi:10.1172/JCI119105)
157. Reich E, Tamary A, Sionov RV & Melloul D 2012 Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated b cell death. Diabetologia 55 1048-1057. (doi:10.1007/s00125-011-2422-z)
158. Renstrom E, Ding WG, Bokvist K & Rorsman P 1996 Neurotransmitterinduced inhibition of exocytosis in insulin-secreting b cells by activation of calcineurin. Neuron 17 513-522. (doi:10.1016/S0896-6273(00)80183-X)
159. Rodriguez-Rodriguez AE, Trinanes J, Velazquez-Garcia S, Porrini E, Vega Prieto MJ, Diez Fuentes ML, Arevalo M, Salido Ruiz E & Torres A 2013 The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. American Journal of Transplantation 13 1665-1675. (doi:10.1111/ajt.12236)
160. Rorsman P & Braun M 2013 Regulation of insulin secretion in human pancreatic islets. Annual Review of Physiology 75 155-179. (doi:10.1146/annurev-physiol-030212-183754)
161. Russell LC, Whitt SR, Chen MS & Chinkers M1999 2006 Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90. Journal of Biological Chemistry 274 20060-20063. (doi:10.1074/jbc.274.29.20060)
162. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D & Kaufman RJ 2006 Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biology 4 e374. (doi:10.1371/journal.pbio. 0040374)
163. Santin I, Moore F, Colli ML, Gurzov EN, Marselli L, Marchetti P & Eizirik DL 2011 PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic b-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 60 3279-3288. (doi:10.2337/db11-0758)
164. Santoro MF, Annand RR, Robertson MM, Peng YW, Brady MJ, Mankovich JA, Hackett MC, Ghayur T, Walter G, Wong WW et al. 1998 Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. Journal of Biological Chemistry 273 13119-13128. (doi:10.1074/jbc.273. 21.13119)
165. Sato Y, Mariot P, Detimary P, Gilon P & Henquin JC 1998 Okadaic acidinduced decrease in the magnitude and efficacy of the Ca2C signal in pancreatic b cells and inhibition of insulin secretion. British Journal of Pharmacology 123 97-105. (doi:10.1038/sj.bjp.0701578)
166. Schwaninger M, Blume R, Kruger M, Lux G, Oetjen E & Knepel W 1995 Involvement of the Ca(2C)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. Journal of Biological Chemistry 270 8860-8866. (doi:10.1074/jbc.270.15.8860)
167. Schwarz S, Hufnagel B, Dworak M, Klumpp S & Krieglstein J 2006 Protein phosphatase type 2Ca and 2Cb are involved in fatty acid-induced apoptosis of neuronal and endothelial cells. Apoptosis 11 1111-1119. (doi:10.1007/s10495-006-6982-1)
168. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR III, Takemori H et al. 2004 The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119 61-74. (doi:10.1016/j.cell.2004.09.015)
169. Sents W, Ivanova E, Lambrecht C, Haesen D & Janssens V 2013 The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity. FEBS Journal 280 644-661. (doi:10.1111/j.1742-4658.2012.08579.x)
170. Shao J, Hartson SD & Matts RL 2002 Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2a kinase. Biochemistry 41 6770-6779. (doi:10.1021/bi025737a)
171. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M & Cantley LC 2005 The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 1642-1646. (doi:10.1126/science.1120781)
172. Shi Y 2009 Serine/threonine phosphatases: mechanism through structure. Cell 139 468-484. (doi:10.1016/j.cell.2009.10.006)
173. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB & Unger RH 1998 Lipoapoptosis in b-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. Journal of Biological Chemistry 273 32487-32490. (doi:10.1074/jbc.273.49.32487)
174. Silverstein AM, Galigniana MD, Chen MS, Owens-Grillo JK, Chinkers M & Pratt WB 1997 Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin. Journal of Biological Chemistry 272 16224-16230. (doi:10.1074/jbc.272.26.16224)
175. Sinclair C, Borchers C, Parker C, Tomer K, Charbonneau H & Rossie S 1999 The tetratricopeptide repeat domain and a C-terminal region control the activity of Ser/Thr protein phosphatase 5. Journal of Biological Chemistry 274 23666-23672. (doi:10.1074/jbc.274.33.23666)
176. Sjöholm Å 1991 Phorbol ester stimulation of pancreatic b-cell replication, polyamine content and insulin secretion. FEBS Letters 294 257-260. (doi:10.1016/0014-5793(91)81442-B)
177. Sjöholm Å 1994 Inhibitory effects of cyclosporin A on rat insulinoma cell proliferation, polyamine content and insulin secretion. Molecular and Cellular Endocrinology 99 21-24. (doi:10.1016/0303-7207(94)90141-4)
178. Sjöholm Å 1995 Ceramide inhibits pancreatic b-cell insulin production and mitogenesis and mimics the actions of interleukin-1b. FEBS Letters 367 283-286. (doi:10.1016/0014-5793(95)00470-T)
179. Sjöholm Å 1996 Diabetes mellitus and impaired pancreatic b-cell proliferation. Journal of Internal Medicine 239 211-220. (doi:10.1046/j.1365-2796.1996.377740000.x)
180. Sjöholm Å 1998 Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets. Endocrine 9 1-13. (doi:10.1385/ENDO:9:1:1)
181. Sjöholm Å & Honkanen RE 2000 Polyamines regulate serine/threonine protein phosphatases in insulin-secreting cells. Pancreas 20 32-37. (doi:10.1097/00006676-200001000-00005)
182. Sjöholm Å , Arkhammar P, Welsh N, Bokvist K, Rorsman P, Hallberg A, Nilsson T,WelshM& Berggren PO 1993a Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2C, inositol phosphate generation, and phorbol ester sensitivity. Journal of Clinical Investigation 92 1910-1917. (doi:10.1172/JCI116784)
183. Sjöholm Å, Honkanen RE & Berggren PO 1993b Characterization of serine/threonine protein phosphatases in RINm5F insulinoma cells. Bioscience Reports 13 349-358. (doi:10.1007/BF01150479)
184. Sjöholm Å , Honkanen RE & Berggren PO 1995 Inhibition of serine/threonine protein phosphatases by secretagogues in insulin-secreting cells. Endocrinology 136 3391-3397.
185. Sjöholm Å , Lehtihet M, Efanov AM, Zaitsev SV, Berggren PO & Honkanen RE 2002 Glucose metabolites inhibit protein phosphatases and directly promote insulin exocytosis in pancreatic b-cells. Endocrinology 143 4592-4598. (doi:10.1210/en.2002-220672)
186. Skarra DV, Goudreault M, Choi H, Mullin M, Nesvizhskii AI, Gingras AC & Honkanen RE 2011 Label-free quantitative proteomics and SAINT analysis enable interactome mapping for the human Ser/Thr protein phosphatase 5. Proteomics 11 1508-1516. (doi:10.1002/pmic. 201000770)
187. Soleimanpour SA, Crutchlow MF, Ferrari AM, Raum JC, Groff DN, Rankin MM, Liu C, De Leon DD, Naji A, Kushner JA et al. 2010 Calcineurin signaling regulates human islet {b}-cell survival. Journal of Biological Chemistry 285 40050-40059. (doi:10.1074/jbc.M110.154955)
188. Sutherland EW Jr & Wosilait WD 1955 Inactivation and activation of liver phosphorylase. Nature 175 169-170. (doi:10.1038/175169a0)
189. Swingle MR, Honkanen RE & Ciszak EM 2004 Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5. Journal of Biological Chemistry 279 33992-33999. (doi:10.1074/jbc. M402855200)
190. Swingle M, Ni L & Honkanen RE 2007 Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods in Molecular Biology 365 23-38.
191. Taira J & Higashimoto Y 2013 Caveolin-1 interacts with protein phosphatase 5 and modulates its activity in prostate cancer cells. Biochemical and Biophysical Research Communications 431 724-728. (doi:10.1016/j.bbrc.2013.01.051)
192. Taljedal IB 1967 Electrophoretic studies on phosphatases from the pancreatic islets of obese-hyperglycaemic mice. Acta Endocrinologica 55 153-162.
193. Tamagawa T, Iguchi A, Uemura K, Miura H, Nonogaki K, Ishiguro T & Sakamoto N 1992 Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets. Endocrinologia Japonica 39 325-329. (doi:10.1507/endocrj1954.39.325)
194. Tamura K, Fujimura T, Tsutsumi T, Nakamura K, Ogawa T, Atumaru C, Hirano Y, Ohara K, Ohtsuka K, Shimomura K et al. 1995 Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic b-cell. Transplantation 59 1606-1613. (doi:10.1097/00007890-199506000-00018)
195. Taylor SS & Kornev AP 2011 Protein kinases: evolution of dynamic regulatory proteins. Trends in Biochemical Sciences 36 65-77. (doi:10.1016/j.tibs.2010.09.006)
196. Tengholm A & Gylfe E 2009 Oscillatory control of insulin secretion. Molecular and Cellular Endocrinology 297 58-72. (doi:10.1016/j.mce. 2008.07.009)
197. Terrak M, Kerff F, Langsetmo K, Tao T & Dominguez R 2004 Structural basis of protein phosphatase 1 regulation. Nature 429 780-784. (doi:10.1038/nature02582)
198. Thomas H, Senkel S, Erdmann S, Arndt T, Turan G, Klein-Hitpass L & Ryffel GU 2004 Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4a and HNF1b in a pancreatic b-cell line. Nucleic Acids Research 32 e150. (doi:10.1093/nar/gnh144)
199. Todd JA,Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F et al. 2007 Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 39 857-864. (doi:10.1038/ng2068)
200. Torii S 2009 Expression and function of IA-2 family proteins, unique neuroendocrine-specific protein-tyrosine phosphatases. Endocrine Journal 56 639-648. (doi:10.1507/endocrj.K09E-157)
201. Tumlin JA, Lea JP, Swanson CE, Smith CL, Edge SS & Someren JS 1997 Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins. Journal of Clinical Investigation 99 1217-1223. (doi:10.1172/JCI119278)
202. Tunon MJ, Sanchez-Campos S, Gutierrez B, Culebras JM & Gonzalez-Gallego J 2003 Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes. Biochemical Pharmacology 66 439-445. (doi:10.1016/S0006-2952(03)00288-0)
203. Vander Mierde D, Scheuner D, Quintens R, Patel R, Song B, Tsukamoto K, Beullens M, Kaufman RJ, Bollen M& Schuit FC 2007 Glucose activates a protein phosphatase-1-mediated signaling pathway to enhance overall translation in pancreatic b-cells. Endocrinology 148 609-617. (doi:10.1210/en.2006-1012)
204. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF & Reed JC 1999 Ca2C-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284 339-343. (doi:10.1126/science.284.5412.339)
205. Ward WK, Bolgiano DC, McKnight B, Halter JB & Porte D Jr 1984 Diminished B cell secretory capacity in patients with noninsulindependent diabetes mellitus. Journal of Clinical Investigation 74 1318-1328. (doi:10.1172/JCI111542)
206. Vaughan CK, Mollapour M, Smith JR, Truman A, Hu B, Good VM, Panaretou B, Neckers L, Clarke PA, Workman P et al. 2008 Hsp90-dependent activation of protein kinases is regulated by chaperonetargeted dephosphorylation of Cdc37. Molecular Cell 31 886-895. (doi:10.1016/j.molcel.2008.07.021)
207. Veluthakal R, Wadzinski BE & Kowluru A 2006 Localization of a nuclear serine/threonine protein phosphatase in insulin-secreting INS-1 cells:potential regulation by IL-1b. Apoptosis 11 1401-1411. (doi:10.1007/s10495-006-8371-1)
208. Virshup DM & Shenolikar S 2009 From promiscuity to precision: protein phosphatases get a makeover. Molecular Cell 33 537-545. (doi:10.1016/j.molcel.2009.02.015)
209. Wechsler T, Chen BP, Harper R, Morotomi-Yano K, Huang BC, Meek K, Cleaver JE, Chen DJ & Wabl M 2004 DNA-PKcs function regulated specifically by protein phosphatase 5. PNAS 101 1247-1252. (doi:10.1073/pnas.0307765100)
210. Welsh N 1996 Interleukin-1b-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. Journal of Biological Chemistry 271 8307-8312. (doi:10.1074/jbc.271.4.2121)
211. Welters HJ, Senkel S, Klein-Hitpass L, Erdmann S, Thomas H, Harries LW, Pearson ER, Bingham C, Hattersley AT, Ryffel GU et al. 2006 Conditional expression of hepatocyte nuclear factor-1b, the maturityonset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic b-cells. Journal of Endocrinology 190 171-181. (doi:10.1677/joe.1.06768)
212. Welters HJ, Oknianska A, Erdmann KS, Ryffel GU & Morgan NG 2008 The protein tyrosine phosphatase-BL, modulates pancreatic b-cell proliferation by interaction with the Wnt signalling pathway. Journal of Endocrinology 197 543-552. (doi:10.1677/JOE-07-0262)
213. Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG & Kasibhatla B 2005 A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Experimental Biology and Medicine 230 207-216.
214. Wishart MJ & Dixon JE 2002 PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Trends in Cell Biology 12 579-585. (doi:10.1016/S0962-8924(02)02412-1)
215. Xu X, Lagercrantz J, Zickert P, Bajalica-Lagercrantz S & Zetterberg A 1996 Chromosomal localization and 50 sequence of the human protein serine/threonine phosphatase 50 gene. Biochemical and Biophysical Research Communications 218 514-517. (doi:10.1006/bbrc.1996.0092)
216. Xu Y, Chen Y, Zhang P, Jeffrey PD & Shi Y 2008 Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Molecular Cell 31 873-885. (doi:10.1016/j.molcel. 2008.08.006)
217. Yamaguchi Y, Katoh H, Mori K & Negishi M 2002 Ga(12) and Ga(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity. Current Biology 12 1353-1358. (doi:10.1016/S0960-9822(02)01034-5)
218. Yamaguchi F, Yamamura S, Shimamoto S, Tokumitsu H, Tokuda M & Kobayashi R 2014 Suramin is a novel activator of PP5 and biphasically modulates S100-activated PP5 activity. Applied Biochemistry and Biotechnology 172 237-247. (doi:10.1007/s12010-013-0522-6)
219. Yan L, Nairn AC, Palfrey HC & Brady MJ 2003 Glucose regulates EF-2 phosphorylation and protein translation by a protein phosphatase-2Adependent mechanism in INS-1-derived 832/13 cells. Journal of Biological Chemistry 278 18177-18183. (doi:10.1074/jbc.M301116200)
220. Yan L, Guo S, Brault M, Harmon J, Robertson RP, Hamid R, Stein R & Yang E 2012 The B55a-containing PP2A holoenzyme dephosphorylates FOXO1 in islet b-cells under oxidative stress. Biochemical Journal 444 239-247. (doi:10.1042/BJ20111606)
221. Yang J, Roe SM, Cliff MJ, Williams MA, Ladbury JE, Cohen PT & Barford D 2005 Molecular basis for TPR domain-mediated regulation of protein phosphatase 5. EMBO Journal 24 1-10. (doi:10.1038/sj.emboj.7600496)
222. Ylipaasto P, Kutlu B, Rasilainen S, Rasschaert J, Salmela K, Teerijoki H, Korsgren O, Lahesmaa R, Hovi T, Eizirik DL et al. 2005 Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 48 1510-1522. (doi:10.1007/s00125-005-1839-7)
223. Yong W, Bao S, Chen H, Li D, Sanchez ER & Shou W 2007 Mice lacking protein phosphatase 5 are defective in ataxia telangiectasia mutated (ATM)-mediated cell cycle arrest. Journal of Biological Chemistry 282 14690-14694. (doi:10.1074/jbc.C700019200)
224. Zhang AQ, Gao ZY, Gilon P, Nenquin M, Drews G & Henquin JC 1991 Vanadate stimulation of insulin release in normal mouse islets. Journal of Biological Chemistry 266 21649-21656.
225. Zhang J, Bao S, Furumai R, Kucera KS, Ali A, Dean NM & Wang XF 2005 Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Molecular and Cellular Biology 25 9910-9919. (doi:10.1128/MCB.25.22.9910-9919.2005)
226. Zhao S & Sancar A 1997 Human blue-light photoreceptor hCRY2 specifically interacts with protein serine/threonine phosphatase 5 and modulates its activity. Photochemistry and Photobiology 66 727-731. (doi:10.1111/j.1751-1097.1997.tb03214.x)
227. Zhou G, Golden T, Aragon IV & Honkanen RE 2004 Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. Journal of Biological Chemistry 279 46595-46605. (doi:10.1074/jbc. M408320200)